Abstract:Infantile hemangiopericytoma is a rare tumour of infancy and a very rare cause of inspiratory stridor in this age group. The mainstay of treatment is surgery. The overall prognosis is favourable but because of the unpredictable nature of the tumour, long-term follow-up is recommended.
“…There is no ideal chemotherapy regimen , but the most commonly used drugs are vincristine, actinomycin D, cyclophosphamide, methotrexate, doxorubicin, prednisone, and dacarbazine .…”
Section: Discussionmentioning
confidence: 99%
“…Some authors believe that it originates from Zimmermann's vascular pericytes, which are contractile fusiform cells that surround capillaries and postcapillary venules , but the exact origin of the lesion is unclear. Given that the clinical and pathologic features overlap with those of myofibromatosis and solitary fibrous tumor (SFT), it has been suggested that these three entities are related variants of a continuous spectrum and that their histologic characteristics may correspond to different stages of maturation . Infantile myofibromatosis often has a marked biphasic pattern with an area of plump spindle cells arranged in short fascicles and an area of more round or oval cells around blood vessels, whereas HPC has a greater prominence of oval cells around blood vessels .…”
Section: Discussionmentioning
confidence: 99%
“…Surgical excision is still the first choice of treatment , because it is associated with good prognosis and low relapse rate. Complete tumor excision and adjuvant chemotherapy reduce the risk of local recurrence .…”
Congenital hemangiopericytoma (HPC) is a rare mesenchymal tumor with less aggressive behavior and a more favorable prognosis than similar tumors in adults. Multifocal presentation is even less common than isolated HPC and hence its clinical and histologic recognition may be challenging. A newborn infant with multifocal congenital HPC causing severe deformity but with a favorable outcome after chemotherapy and surgical removal is reported.
“…There is no ideal chemotherapy regimen , but the most commonly used drugs are vincristine, actinomycin D, cyclophosphamide, methotrexate, doxorubicin, prednisone, and dacarbazine .…”
Section: Discussionmentioning
confidence: 99%
“…Some authors believe that it originates from Zimmermann's vascular pericytes, which are contractile fusiform cells that surround capillaries and postcapillary venules , but the exact origin of the lesion is unclear. Given that the clinical and pathologic features overlap with those of myofibromatosis and solitary fibrous tumor (SFT), it has been suggested that these three entities are related variants of a continuous spectrum and that their histologic characteristics may correspond to different stages of maturation . Infantile myofibromatosis often has a marked biphasic pattern with an area of plump spindle cells arranged in short fascicles and an area of more round or oval cells around blood vessels, whereas HPC has a greater prominence of oval cells around blood vessels .…”
Section: Discussionmentioning
confidence: 99%
“…Surgical excision is still the first choice of treatment , because it is associated with good prognosis and low relapse rate. Complete tumor excision and adjuvant chemotherapy reduce the risk of local recurrence .…”
Congenital hemangiopericytoma (HPC) is a rare mesenchymal tumor with less aggressive behavior and a more favorable prognosis than similar tumors in adults. Multifocal presentation is even less common than isolated HPC and hence its clinical and histologic recognition may be challenging. A newborn infant with multifocal congenital HPC causing severe deformity but with a favorable outcome after chemotherapy and surgical removal is reported.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.